Early-stage visual processing and cortical amplification deficits in schizophrenia

Archives of General Psychiatry

Volumn 62, Issue 5, 2005, Pages 495-504

  Butler, Pamela D ^a,b   Zemon, Vance ^c   Schechter, Isaac ^a   Saperstein, Alice M ^a   Hoptman, Matthew J ^a,b   Lim, Kelvin O ^d   Revheim, Nadine ^a   Silipo, Gail ^a   Javitt, Daniel C ^a,b  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c YESHIVA UNIVERSITY   (United States)

^d UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CONTRAST SENSITIVITY; CONTROLLED STUDY; ELECTROPHYSIOLOGY; EVOKED VISUAL RESPONSE; FEMALE; GIANT CELL; HUMAN; INFORMED CONSENT; MALE; MICHAELIS MENTEN KINETICS; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOPHYSICS; SCHIZOPHRENIA; STRUCTURE ACTIVITY RELATION; VISUAL CORTEX; VISUAL SYSTEM; WHITE MATTER;

ADULT; AGNOSIA; AMBULATORY CARE; CONTRAST SENSITIVITY; EVOKED POTENTIALS, VISUAL; FEMALE; GLUTAMATES; HOSPITALIZATION; HOSPITALS, PSYCHIATRIC; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RECEPTORS, N-METHYL-D-ASPARTATE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; THALAMUS; VISUAL CORTEX; VISUAL PATHWAYS; VISUAL PERCEPTION;

EID: 18244366892     PISSN: 0003990X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpsyc.62.5.495     Document Type: Article

References (84)

1. Goldman-Rakic PS. Working memory dysfunction in schizophrenia. J Neuropsychiatry Clin Neurosci. 1994;6:348-357.
2. Goldberg TE, Gold JM. Neurocognitive functioning in patients with schizophrenia: an overview. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology, the Fourth Generation of Progress. New York, NY: Raven Press Ltd; 1995:1245-1257.
3. Weinberger DR, Gallhofer B. Cognitive function in schizophrenia. Int Clin Psychopharmacol. 1997;12(suppl 4):S29-S36.
4. Green MF. Schizophrenia From a Neurocognitive Perspective. Boston, Mass: Allyn & Bacon; 1998.
5. Adler LE, Freedman R, Ross RG, Olincy A, Waldo MC. Elementary phenotypes in the neurobiological and genetic study of schizophrenia. Biol Psychiatry. 1999; 46:8-18.
6. Braff DL, Saccuzzo DP, Geyer MA. Information processing dysfunctions in schizophrenia: studies of visual backward masking, sensorimotor gating, and habituation. In: Steinhauer SR, Gruzelier JH, Zubin J, eds. Handbook of Schizophrenia. Vol 5. New York, NY: Elsevier; 1991:303-334.
7. Javitt DC, Liederman E, Cienfuegos A, Shelley AM. Panmodal processing imprecision as a basis for dysfunction of transient memory storage systems in schizophrenia. Schizophr Bull. 1999;25:763-775.
8. Turetsky BI, Moberg PJ, Owzar K, Johnson SC, Doty RL, Gur RE. Physiologic impairment of olfactory stimulus processing in schizophrenia. Biol Psychiatry. 2003;53:403-411.
9. Butler PD, Schechter I, Zemon V, Schwartz SG, Greenstein VC, Gordon J, Schroeder CE, Javitt DC. Dysfunction of early stage visual processing in schizophrenia. Am J Psychiatry. 2001;158:1126-1133.
10. Butler PD, DeSanti LA, Maddox J, Harkavy-Friedman JM, Amador XF, Goetz RR, Javitt DC, Gorman JM. Visual backward-masking deficits in schizophrenia: relationship to visual pathway function and symptomatology. Schizophr Res. 2003; 59:199-209.
11. Braus DF, Weber-Fahr W, Tost H, Ruf M, Henn FA. Sensory information processing in neuroleptic-naive first-episode schizophrenic patients: a functional magnetic resonance imaging study. Arch Gen Psychiatry. 2002;59:696-701.
12. Brenner CA, Lysaker PH, Wilt MA, O'Donnell BF. Visual processing and neuropsychological function in schizophrenia and schizoaffective disorder. Psychiatry Res. 2002;111:125-136.
13. Cadenhead KS, Serper Y, Braff DL. Transient versus sustained visual channels in the visual backward masking deficits of schizophrenia patients. Biol Psychiatry. 1998;43:132-138.
14. Chen Y, Nakayama K, Levy D, Matthysse S, Holzman P. Processing of global, but not local, motion direction is deficient in schizophrenia. Schizophr Res. 2003; 61:215-227.
15. Doniger GM, Foxe JJ, Murrary MM, Higgins BA, Javitt DC. Impaired visual object recognition and dorsal/ventral stream interaction in schizophrenia. Arch Gen Psychiatry. 2002;59:1011-1020.
16. Green MF, Mintz J, Salveson D, Nuechterlein KH, Breitmeyer B, Light GA, Braff DL. Visual masking as a probe for abnormal gamma range activity in schizophrenia. Biol Psychiatry. 2003;53:1113-1119.
17. Li CS. Impaired detection of visual motion in schizophrenia patients. Prog Neuropsychopharmacol Biol Psychiatry. 2002;26:929-934.
18. Schechter I, Butler PD, Silipo G, Zemon V, Javitt DC. Magnocellular and parvocellular contributions to backward masking dysfunction in schizophrenia. Schizophr Res. 2003;64:91-101.
19. Schwartz BD, Maron BA, Evans WJ, Winstead DK. High velocity transient visual processing deficits diminish ability of patients with schizophrenia to recognize objects. Neuropsychiatry Neuropsychol Behav Neurol. 1999;12:170-177.
20. Slaghuis WL. Contrast sensitivity for stationary and drifting spatial frequency gratings in positive- and negative-symptom schizophrenia. J Abnorm Psychol. 1998; 107:49-62.
21. Keri S, Antal A, Szekeres G, Benedek G, Janka Z. Spatiotemporal visual processing in schizophrenia. J Neuropsychiatry Clin Neurosci. 2002;14:190-196.
22. Gold JM, Goldberg RW, McNary SW, Dixon LB, Lehman AF. Cognitive correlates of job tenure among patients with severe mental illness. Am J Psychiatry. 2002;159:1395-1402.
23. Sergi MJ, Green MF. Social perception and early visual processing in schizophrenia. Schizophr Res. 2003;59:233-241.
24. Dacey DM, Petersen MR. Dendritic field size and morphology of midget and parasol ganglion cells of the human retina. Proc Natl Acad Sci U S A. 1992;89:9666-9670.
25. Casagrande VA, Xu X. Parallel visual pathways: a comparative perspective. In: Chalupa LM, Werner JS, eds. The Visual Neurosciences. Vol 1. Cambridge, Mass: MIT Press; 2003.
26. Orban GA, Van Essen D, Vanduffel W. Comparative mapping of higher visual areas in monkeys and humans. Trends Cogn Sci. 2004;8:315-324.
27. Merigan WH, Maunsell JHR. How parallel are the primate visual pathways? In: Cowan WM, Shooter EM, Stevens CF, Thompson RF, eds. Annual Review of Neuroscience. Palo Alto, Calif: Annual Reviews, Inc; 1993:369-402.
28. Vidyasagar TR. A neuronal model of attentional spotlight: parietal guiding the temporal. Brain Res Brain Res Rev. 1999;30:66-76.
29. Steinman B, Steinman S, Lehmkuhle S. Transient visual attention is dominated by the magnocellular stream. Vision Res. 1997;37:17-23.
30. Norman J. Two visual systems and two theories of perception: an attempt to reconcile the constructivist and ecological approaches. Behav Brain Sci. 2002;25:73-144.
31. Thiele A, Dobkins KR, Albright TD. Neural correlates of chromatic motion perception. Neuron. 2001;32:351-358.
32. Maunsell JH, Nealey TA, DePriest DD. Magnocellular and parvocellular contributions to responses in the middle temporal visual area (MT) of the macaque monkey. J Neurosci. 1990;10:3323-3334.
33. Ardekani BA, Nierenberg J, Hoptman MJ, Javitt DC, Lim KO. MRI study of white matter diffusion anisotropy in schizophrenia. Neuroreport. 2003;14:2025-2029.
34. Basser PJ, Mattiello J, LeBihan D. MR diffusion tensor spectroscopy and imaging. Biophys J. 1994;66:259-267.
35. Kaplan E. The receptive field structure of retinal ganglion cells in cat and monkey. In: Leventhal AG, ed. Vision and Visual Dysfunction. Boston, Mass: CRC Press; 1991:10-40.
36. Tootell RB, Hamilton SL, Switkes E. Functional anatomy of macaque striate cortex. IV. Contrast and magno-parvo streams. J Neurosci. 1988;8:1594-1609.
37. Kwon YH, Nelson SB, Toth LJ, Sur M. Effect of stimulus contrast and size on NMDA receptor activity in cat lateral geniculate nucleus. J Neurophysiol. 1992; 68:182-196.
38. Fox K, Sato H, Daw N. The effect of varying stimulus intensity on NMDA-receptor activity in cat visual cortex. J Neurophysiol. 1990;64:1413-1428.
39. Jindra LF, Zemon V. Contrast sensitivity testing: a more complete assessment of vision. J Cataract Refract Surg. 1989;15:141-148.
40. Chen Y, Palafox GP, Nakayama K, Levy DL, Matthysse S, Holzman PS. Motion perception in schizophrenia. Arch Gen Psychiatry. 1999;56:149-154.
41. Greenstein VC, Seliger S, Zemon V, Ritch R. Visual evoked potential assessment of the effects of glaucoma on visual subsystems. Vision Res. 1998;38:1901-1911.
42. Cornblatt BA, Malhotra AK. Impaired attention as an endophenotype for molecular genetic studies of schizophrenia. Am J Med Genet. 2001;105:11-15.
43. Ammons R, Ammons C. The Quick Test (QT): provisional manual. Psychol Rep. 1962;11:111-162.
44. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition. New York: New York State Psychiatric Institute; 1997.
45. Zemon V, Gordon J, Welch J. Asymmetries in ON and OFF visual pathways of humans revealed using contrast-evoked cortical potentials. Vis Neurosci. 1988; 1:145-150.
46. Jasper HH. Appendix to report to Committee on Clinical Examination in EEG: the ten-twenty electrode system of the International Federation. Electroencephalogr Clin Neurophysiol. 1958;10:371-375.
47. Victor JD, Mast J. A new statistic for steady-state evoked potentials. Electroencephilogr Clin Neurophysiol. 1991;78:378-388.
48. Zemon V, Hartmann EE, Gordon J, Prunte-Glowazki A. An electrophysiological technique for assessment of the development of spatial vision. Optom Vis Sci. 1997;74:708-716.
49. Wetherill GB, Levitt H. Sequential estimation of points on a psychometric function. Br J Math Stat Psychol. 1965;18:1-10.
50. Hoptman MJ, Volavka J, Johnson G, Weiss E, Bilder RM, Lim KO. Frontal white matter microstructure, aggression, and impulsivity in men with schizophrenia: a preliminary study. Biol Psychiatry. 2002;52:9-14.
51. Loeb PA. ILS: Independent Living Scales Manual. San Antonio, Tex: The Psychological Corp, Harcourt Race Jovanovich, Inc; 1996.
52. Revheim N, Medalia A. Verbal memory, problem-solving skills and community status in schizophrenia. Schizophr Res. 2004;68:149-158.
53. Brenner CA, Wilt MA, Lysaker PH, Koyfman A, O'Donnell BF. Psychometrically matched visual-processing tasks in schizophrenia spectrum disorders. J Abnorm Psychol. 2003;112:28-37.
54. Saccuzzo DP, Braff DL. Information-processing abnormalities: trait- and state-dependent components. Schizophr Bull. 1986;12:447-459.
55. Butler PD, Harkavy-Friedman JM, Amador XF, Gorman JM. Backward masking in schizophrenia: relationship to medication status, neuropsychological functioning, and dopamine metabolism. Biol Psychiatry. 1996;40:295-298.
56. Agartz I, Andersson JL, Skare S. Abnormal brain white matter in schizophrenia: a diffusion tensor imaging study. Neuroreport. 2001;12:2251-2254.
57. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage. 2003;20:1714-1722.
58. Javitt DC, Zukin SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301-1308.
59. Olney JW, Farber NB. Glutamate receptor dysfunction and schizophrenia. Arch Gen Psychiatry. 1995;52:998-1007.
60. Tsai G, Coyle JT. Glutamatergic mechanisms in schizophrenia. Annu Rev Pharmacol Toxicol. 2002;42:165-179.
61. Javitt DC, Steinschneider M, Schroeder CE, Arezzo JC. Role of cortical N-methyl-D-aspartate receptors in auditory sensory memory and mismatch negativity generation: implications for schizophrenia. Proc Natl Acad Sci U S A. 1996;93:11962-11967.
62. Javitt DC, Jayachandra M, Lindsley RW, Specht CM, Schroeder CE. Schizophrenia-like deficits in auditory P1 and N1 refractoriness induced by the psychomimetic agent phencyclidine (PCP). Clin Neurophysiol. 2000;111:833-836.
63. Umbricht D, Schmid L, Koller R, Vollenweider FX, Hell D, Javitt DC. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch Gen Psychiatry. 2000;57:1139-1147.
64. Krystal JH, Karper LP, Seibyl JP, Freeman GK, Delaney R, Bremner JD, Heninger GR, Bowers MB Jr, Charney DS. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans: psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry. 1994;51:199-214.
65. Krystal JH, Bennett A, Abi-Saab D, Belger A, Karper LP, D'Souza DC, Lipschitz D, Abi-Dargham A, Charney DS. Dissociation of ketamine effects on rule acquisition and rule implementation: possible relevance to NMDA receptor contributions to executive cognitive functions. Biol Psychiatry. 2000;47:137-143.
66. Heresco-Levy U, Javitt DC, Ermilov M, Mordel C, Silipo G, Lichtenstein M. Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia. Arch Gen Psychiatry. 1999;56:29-36.
67. Javitt DC, Zylberman I, Zukin SR, Heresco-Levy U, Lindenmayer JP. Amelioration of negative symptoms in schizophrenia by glycine. Am J Psychiatry. 1994;151:1234-1236.
68. Tsai G, Yang P, Chung LC, Lange N, Coyle JT. D-serine added to antipsychotics for the treatment of schizophrenia. Biol Psychiatry. 1998;44:1081-1089.
69. Slaghuis WL, Thompson AK. The effect of peripheral visual motion on focal contrast sensitivity in positive- and negative-symptom schizophrenia. Neuropsychologia. 2003;41:968-980.
70. Schwartz BD, McGinn T, Winstead DK. Disordered spatiotemporal processing in schizophrenics. Biol Psychiatry. 1987;22:688-698.
71. Chen Y, Levy DL, Sheremata S, Nakayama K, Matthysse S, Holzman PS. Effects of typical, atypical, and no antipsychotic drugs on visual contrast detection in schizophrenia. Am J Psychiatry. 2003;160:1795-1801.
72. Keri S, Kelemen O, Benedek G, Janka Z. Vernier threshold in patients with schizophrenia and in their unaffected siblings. Neuropsychology. 2004;18:537-542.
73. Stuve TA, Friedman L, Jesberger JA, Gilmore GC, Strauss ME, Meltzer HY. The relationship between smooth pursuit performance, motion perception and sustained visual attention in patients with schizophrenia and normal controls. Psychol Med. 1997;27:143-152.
74. O'Donnell BF, Swearer JM, Smith LT, Nestor PG, Shenton ME, McCarley RW. Selective deficits in visual perception and recognition in schizophrenia. Am J Psychiatry. 1996;153:687-692.
75. Rivadulla C, Sharma J, Sur M. Specific roles of NMDA and AMPA receptors in direction-selective and spatial phase-selective responses in visual cortex. J Neurosci. 2001;21:1710-1719.
76. Bowen L, Wallace CJ, Glynn SM, Nuechterlein KH, Lutzker JR, Kuehnel TG. Schizophrenic individuals' cognitive functioning and performance in interpersonal interactions and skills training procedures. J Psychiatr Res. 1994;28:289-301.
77. Braff DL, Saccuzzo DP. Effect of antipsychotic medication on speed of information processing in schizophrenic patients. Am J Psychiatry. 1982;139:1127-1130.
78. Cadenhead KS, Geyer MA, Butler RW, Perry W, Sprock J, Braff DL. Information processing deficits of schizophrenia patients: relationship to clinical ratings, gender and medication status. Schizophr Res. 1997;28:51-62.
79. Harvey PD, Keefe RS, Moskowitz J, Putnam KM, Mohs RC, Davis KL. Attentional markers of vulnerability to schizophrenia: performance of medicated and unmedicated patients and normals. Psychiatry Res. 1990;33:179-188.
80. Brody D, Saccuzzo DP, Braff DL. Information processing for masked and unmasked stimuli in schizophrenia and old age. J Abnorm Psychol. 1980;89:617-622.
81. Chen Y, Nakayama K, Levy DL, Matthysse S, Holzman PS. Psychophysical isolation of a motion-processing deficit in schizophrenics and their relatives and its association with impaired smooth pursuit. Proc Natl Acad Sci U S A. 1999;96:4724-4729.
82. Keri S, Kelemen O, Benedek G, Janka Z. Different trait markers for schizophrenia and bipolar disorder: a neurocognitive approach. Psychol Med. 2001;31:915-922.
83. Green MF, Nuechterlein KH, Breitmeyer B. Backward masking performance in unaffected siblings of schizophrenic patients: evidence for a vulnerability indicator [published erratum appears in Arch Gen Psychiatry 1997 Sep;54(9):846]. Arch Gen Psychiatry. 1997;54:465-472.
84. Braff DL. Impaired speed of information processing in nonmedicated schizotypal patients. Schizophr Bull. 1981;7:499-508.